Andrew Schaefer

Dr Andrew Schaefer is a researcher at Newcastle University specializing in mitochondrial genetics and neurogenetics. His work focuses on understanding the clinical and molecular mechanisms of mitochondrial DNA (mtDNA) disorders, particularly autosomal recessive POLG disease, dysferlinopathy, and mtDNA maintenance syndromes. He has contributed to studies on disease progression, genotype-phenotype correlations, and diagnostic methodologies in mitochondrial myopathy and encephalopathy.

• Key research areas: Mitochondrial Genetics, Neurodegenerative Diseases, Molecular Genetics, Clinical Neurology

Publication Trends: His 15 most recent articles (2018–2022) emphasize mitochondrial DNA mutations (e.g., POLG, MT-ND5, DYSF) and their links to neurological conditions like Parkinsonism, ataxia, and myopathy. Collaborations span neurology, cardiology, and genetics.

Notable Contributions: Pioneered research on stroke-like episodes in mitochondrial disease, cardiac manifestations of mtDNA disorders, and biomarker development (e.g., height as a disease severity indicator). His work bridges clinical observations with molecular diagnostics.